[ad_1]
BOSTON (PRWEB)
October 31, 2019
Concerto HealthAI announced today that it is launching its Concerto HealthAI Patient Solutions business that will leverage the company’s expertise in Real-World Data and AI-enabled patient insights. Mike Allelunas will lead this new division as Executive Vice President and General Manager.
Patient Solutions will build on eurekaHealth, Concerto HealthAI’s open, cloud-based, AI technology environment; its oncology and specialty therapeutics expertise; and deep relationships with Specialty Pharmacies. Mike, with more than 20 years of experience in patient-centric healthcare technologies and services, will help accelerate Concerto HealthAI Patient Solutions’ mission of advancing precision medicine and providing Real-world Data and technology solutions for biopharma, pharma, and medical device companies across the patient journey.
Concerto HealthAI is one of the industry’s fastest growing healthcare data and technology startups. Its mission is to transform healthcare through next-generation specialty therapeutics solutions ensuring patients are placed on the most effective therapies and supported over the course of treatment, including enhanced compliance, adherence.
“Patients are at the core of everything we do,” said Jeff Elton, PhD and CEO of Concerto HealthAI. “I am thrilled to welcome Mike and his energy and passion for building technology-driven solutions that benefit patients. Under his leadership our Patient Solutions business can accelerate bringing our new powerful new suite of patient solutions products to market.”
Prior to joining Concerto HealthAI, Mike worked at IQVIA, where he spent 12 years as an executive leading the company’s specialty therapeutics business as well as managing other key businesses. At IQVIA, he focused on technology and services solutions that specifically improved patient insights in support of better utilization and outcomes.
“Concerto HealthAI is investing heavily in AI technologies and data science capabilities across the company,” said Mike Allelunas, EVP and General Manager of Patient Solutions at Concerto HealthAI. “I am excited to lead this new business and to continue to find more value for patients through new and innovative products and solutions.”
About Concerto HealthAI
Concerto HealthAI is a technology leader in Definitive Real-world Data (RWD) and AI solutions for precision oncology. Our mission is to bring together unique data assets, leading AI-based technologies, and the world’s top outcomes research and data science talent. Our focus is on revolutionizing clinical and outcomes research to accelerate the insights benefitting patient treatment. Concerto HealthAI is a SymphonyAI Group company. eurekaHealth is a trademark of Concerto HealthAI. For more information, visit us at http://www.concertohealthai.com.
About SymphonyAI Group
SymphonyAI Group is the fastest-growing private group of B2B AI companies, backed by a $1 billion commitment to deliver next-generation AI solutions for transforming the enterprise. Since its founding in 2017, SymphonyAI Group has grown rapidly to a group of six companies with a combined revenue run rate approaching $300 million. Over 1,600 talented leaders, data scientists, and other professionals operate the group under the leadership of one of Silicon Valley’s most successful serial entrepreneurs, Dr. Romesh Wadhwani. Website: http://www.symphonyai.com
Media Contact:
Jennifer Toole
617-779-1828
concertohealthAI@shiftcomm.com
Share article on social media or email:
[ad_2]